The year-round Mobile Health Clinic will offer health and wellness exams, sports physicals, substance use disorder (SUD) behavioral therapy, acute musculoskeletal issues, blood pressure checks, influenza vaccinations, patient education, and other medical resources.
Jeanine Singer said that with this program McKesson is really focused on what pharmacists are focused on, which is building advocacy around their patients.
Expanded capacity adds to current fill and finish products already 100% manufactured in U.S.
Attendees fostered deeper connections and discovered new ways to strengthen their profession through three days of engaging sessions.
Bresnahan pointed out that community pharmacy needs to diversify,“ to respond to the market shifts, [particularly] as traditional prescription volume starts to shift away from traditional retail pharmacy.”
The paper concludes that, although the negotiation program might reduce drug costs initially, it could threaten the long-term sustainability of the generics and biosimilars market, a key driver of lower prescription costs.
Dave’s Pharmacy delivers innovative clinical services—including point-of-care testing and remote patient monitoring—to elevate patient care.
Buddy Carter is spearheading along with 11 bipartisan members of Congress, including Diana Harshbarger, in introducing the PBM Reform Act, which protects patients and pharmacies from the harmful and anticompetitive business practices of PBMs.
With limited treatment options available to people living with severe alopecia areata in the U.S., the need for innovative therapies such as Leqselvi remains critically important.
This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to build relationships with elected officials at all levels of government.
Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”
The bill establishes powerful transparency requirements, bans spread pricing, assures fair reimbursement for pharmacies, and tackles anti-competitive practices that have driven up drug costs and limited patient choice.
White paper analyzes problems and solutions to patent abuses.
The program will be anchored by IPC’s iCare+ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey.
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases.
Ipratropium bromide nasal solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals.
